6:03 PM
 | 
Apr 20, 2009
 |  BC Extra  |  Company News

EPO to grant Alnylam RNAi patent

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said the European Patent Office issued a notification of intent to grant for the EP1309726 patent in the Tuschl...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >